Additionally, APP and PSEN mutations may influence sporadic AD by disrupting amyloid processing, resulting in the formation of toxic amyloid aggregates that drive neurodegeneration and disease progression (Lanoiselee et al. 2017). Here, APP is linked to Alzheimer disease.